Related references
Note: Only part of the references are listed.Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study
S.M. Sprague et al.
CLINICAL NEPHROLOGY (2011)
238: Reduction of Dietary Phosphorus Absorption With Lanthanum Carbonate or Sevelamer Carbonate: A Balance Study
Raymond Pratt et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
Angel L. M. de Francisco et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials
Sankar D. Navaneethan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4: A Randomized Trial
Stuart M. Sprague et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis
Pieter Evenepoel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The calcium acetate renagel evaluation-2 (CARE-2) study
Wajeh Qunibi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients
Anibal Ferreira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function
Tilman Heinrich et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
W. N. Suki et al.
KIDNEY INTERNATIONAL (2007)
Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: A pilot study
David M. Spiegel et al.
JOURNAL OF RENAL NUTRITION (2007)
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
D. Russo et al.
KIDNEY INTERNATIONAL (2007)
Frequent Hemodialysis Network (FHN) randomized trials: Study design
R. S. Suri et al.
KIDNEY INTERNATIONAL (2007)
Progression of coronary artery calcification in predialysis patients
Domenico Russo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Impact of convective flow on phosphorus removal in maintenance hemodialysis patients
W Lornoy et al.
JOURNAL OF RENAL NUTRITION (2006)
Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers:: A prospective, controlled study
JC Ayus et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
HG Asmus et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: A 6-month, randomized, comparative trial versus calcium carbonate
AJ Hutchison et al.
NEPHRON CLINICAL PRACTICE (2005)
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study)
WY Qunibi et al.
KIDNEY INTERNATIONAL (2004)
A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients
PC D'Haese et al.
KIDNEY INTERNATIONAL (2003)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Share Paper
